Latest International Sales News

Murray Cod Australia reports a near tripling of biomass and strong sales growth in Q4 FY25, while advancing key certifications and expanding market reach.

ReadCloud Limited reported a robust 35% increase in cash receipts for the June quarter, driven by strong growth in its VET-in-Schools segment and disciplined cost management. The company forecasts positive underlying EBITDA and operating cash flow for FY25, positioning itself for accelerated growth in 2026.

Biome Australia Limited has reported a 69% increase in international sales revenue for FY25, reaching $1.5 million, driven by new strategic distribution agreements across Ireland, New Zealand, and Canada.

MyEco Group Ltd reported an 8.6% rise in FY25 sales driven by strong growth in its global MyEco® product line and new UK retail partnerships, while navigating challenges in resin markets and US tariffs.

Botanix Pharmaceuticals clarifies its lead product Sofdra is unlikely to face price cuts under the proposed US executive order on drug pricing, citing its exclusive US market approval and distinct formulations abroad.

SPC Global Holdings confirms FY2025 pro forma EBITDA guidance of A$29 million, driven by strong early post-merger performance and strategic initiatives including site consolidation and leadership renewal.

Vmoto Limited reported a 16% decline in total unit sales for 1Q25, offset by a strong cash position and strategic investments in e-mobility solutions and production capacity.

ImpediMed Limited reported a record A$3.4 million revenue in Q3 FY25, bolstered by a surge in Annual Recurring Revenue and a strategic sales leadership change aimed at accelerating SOZO platform adoption.

Murray Cod Australia Ltd reports a remarkable 192% biomass increase, setting the stage for expanded domestic and international sales from May 2025. The company also advances sustainability certifications and strengthens its board to support growth.

XRF Scientific has reported record half-year revenue and profit for FY25, driven by robust demand from mining and industrial sectors and strategic acquisitions that bolster its market position.

XRF Scientific has reported a record half-year performance, driven by robust mining sector demand and strategic sales growth across its divisions.

XRF Scientific Limited reported a robust half-year performance ending December 2024, with revenue edging up 0.3% to $28.7 million and net profit after tax surging 11.8% to $5.0 million, driven by strong consumables sales and international growth.